1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS

4. MARKET OVERVIEW
4.1. MARKET DRIVERS
4.1.1. DEMAND FOR SPINAL FUSION SURGERIES
4.1.2. GROWTH IN STRATEGIC PARTNERSHIPS
4.1.3. INCREASE IN ORTHOBIOLOGICS MATERIAL
4.2. RESTRAINTS
4.2.1. STRINGENT GOVERNMENT POLICIES
4.2.2. POST-SURGERY COMPLICATIONS
4.3. OPPORTUNITIES
4.3.1. BONE REGENERATION TECHNOLOGY
4.3.2. LARGER SPEND ON HEALTHCARE
4.4. CHALLENGES
4.4.1. HIGH COST OF SPINAL FUSION SURGERY
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
4.4.3. POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE

5. SEGMENTATION
5.1. BY PRODUCTS
5.1.1. DEMINERALIZED BONE MATRIX (DBM)
5.1.2. ALLOGRAFT
5.1.3. BONE MORPHOGENETIC PROTEIN (BMP)
5.1.4. VISCOSUPPLEMENTATION
5.1.5. SYNTHETIC BONE GRAFT SUBSTITUTES
5.1.6. STEM CELL THERAPY
5.1.7. OTHER PRODUCT MARKET
5.2. BY APPLICATION
5.2.1. SPINAL FUSION
5.2.2. TRAUMA REPAIR
5.2.3. RECONSTRUCTIVE SURGERY
5.2.4. TENDON & LIGAMENT REPAIR MARKET
5.2.5. OTHER APPLICATIONS MARKET
5.3. BY END-USER
5.3.1. HOSPITAL MARKET
5.3.2. CLINICS MARKET

6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. VALUE CHAIN ANALYSIS
6.5. VENDOR LANDSCAPE

7. REGIONAL ANALYSIS
7.1. ASIA-PACIFIC ORTHOBIOLOGICS MARKET
7.1.1. INDIA ORTHOBIOLOGICS MARKET
7.1.2. CHINA ORTHOBIOLOGICS MARKET
7.1.3. JAPAN ORTHOBIOLOGICS MARKET
7.1.4. AUSTRALIA ORTHOBIOLOGICS MARKET
7.1.5. ROAPAC ORTHOBIOLOGICS MARKET

8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. MERGERS & ACQUISITIONS

9. COMPANY PROFILE
9.1. BIOVENTUS
9.1.1. OVERVIEW
9.1.2. PRODUCTS PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.2. DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. EXATECH INC
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT ANALYSIS
9.3.4. STRATEGIC ANALYSIS
9.4. GLOBUS MEDICAL INC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT
9.4.5. STRATEGIC ANALYSIS
9.5. INTEGRA LIFESCIENCES HOLDING CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. JOHNSON& JOHNSON
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SCOT ANALYSIS
9.7. MEDTRONIC INC
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT
9.8. NUVASIVE INC
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. RTI SURGICAL
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.10. SANOFI
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.11. STRYKER CORPORATION
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. ZIMMER BIOMET INC
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT ANALYSIS
9.12.5. STRATEGIC ANALYSIS
9.13. MĂ–LNLYCKE HEALTH CARE AB
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS

TABLE LIST
TABLE # 1 OLDER POPULATION BY AGE GROUP: 1900 TO 2050
TABLE # 2 FINANCING FOR ORTHOBIOLOGICS ADVANCEMENT
TABLE # 3 POST-SURGERY COMPLICATIONS
TABLE # 4 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY PRODUCTS 2017-2025 ($ MILLIONS)
TABLE # 5 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE # 6 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE # 7 BONE MORPHOGENETIC PROTEIN (BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE # 8 VISCOSUPPLEMENTATION MARKET 2017-2025 ($ MILLIONS)
TABLE # 9 SYNTHETIC BONE GRAFT MARKET 2017-2025 ($ MILLIONS)
TABLE # 10 STEM CELL THERAPY MARKET 2017-2025 ($ MILLIONS)
TABLE # 11 OTHER PRODUCTS MARKET 2017-2025 ($ MILLIONS)
TABLE # 12 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY APPLICATION 2017-2025 ($ MILLIONS)
TABLE # 13 SPINAL FUSION MARKET 2017-2025 ($ MILLIONS)
TABLE # 14 TRAUMA REPAIR MARKET 2017-2025 ($ MILLIONS)
TABLE # 15 RECONSTRUCTIVE SURGERY MARKET 2017-2025 ($ MILLIONS)
TABLE # 16 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE # 17 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
TABLE # 18 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY END-USER, 2017-2025 ($ MILLION)
TABLE # 19 HOSPITAL ORTHOBIOLOGICS MARKET, 2017-2025 ($ MILLIONS)
TABLE # 20 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)

FIGURES LIST
FIGURE # 1 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE # 2 DEMINERALIZED BONE MATRIX ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 3 ALLOGRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 4 BONE MORPHOGENIC PROTEIN (BMP) ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 5 VISCOSUPPLEMENTATION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 6 SYNTHETIC BONE GRAFT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 7 STEM CELL THERAPY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 8 ASIA-PACIFIC OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE # 9 SPINAL FUSION ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 10 TRAUMA REPAIR ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 11 RECONSTRUCTIVE SURGERY ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 12 TENDON & LIGAMENT ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE # 13 OTHER APPLICATIONS ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLIONS)
FIGURE #14 COST OF KNEE REPLACEMENT IN DEVELOPING COUNTRIES IN 2017
FIGURE #15 ORTHOBIOLOGICS HOSPITAL MARKET 2017-2025 ($ MILLIONS)
FIGURE #16 ORTHOBIOLOGICS CLINICS MARKET 2017-2025 ($ MILLIONS)
FIGURE #17 ASIA-PACIFIC ORTHOBIOLOGICS MARKET BY COUNTRY 2016 & 2025
FIGURE #18 POPULATION AGES 65 AND ABOVE IN TOP 3 COUNTRIES IN ASIA-PACIFIC (% OF TOTAL)
FIGURE #19 INDIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE #20 CHINA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE #21 JAPAN ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE #22 AUSTRALIA ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)
FIGURE #23 ROAPAC ORTHOBIOLOGICS MARKET 2017-2025 ($ MILLION)